Journal of Neurology Research, ISSN 1923-2845 print, 1923-2853 online, Open Access
Article copyright, the authors; Journal compilation copyright, J Neurol Res and Elmer Press Inc
Journal website http://www.neurores.org

Original Article

Volume 10, Number 5, October 2020, pages 183-187

What Antipsychotic Medications and Risk Factors Are Associated With More Relapses in Chronic Schizophrenia Patients?

Tables

Table 1. Demographic Characteristics of the Patients
 
Patients with 3 or < 3 admissionsPatients with > 3 admissionsP value
FHx: family history.
Age (mean)37.8244.010.42
Female (%)81 (45%)41 (41%)0.78
Married (%)56 (28.3%)35 (36.5)0.108
High school diploma (%)69 (34.8%)37 (38.5%)0.374
Rural resident (%)48 (24.2%)21 (21.9%)0.653
Positive FHx of schizophrenia (%)55 (27.8%)27 (28.1%)0.95

 

Table 2. Clinical Characteristics of the Patients
 
Patients with 3 or < 3 admissionsPatients with > 3 admissionsP value
ECT: electroconvulsive therapy.
With negative symptoms (%)28 (14.1%)12 (12.5%)0.72
ECT administered (%)61 (30.8%)74 (77.1%)0.001
Substance abuse (%)65 (32.8%)41 (42.7%)0.09

 

Table 3. Dominant Antipsychotic Medications Used by the Patients
 
Patients with 3 or < 3 admissionsPatients with > 3 admissionsP value
Risperidone78 (46.9%)37 (41%)0.486
Olanzapine38 (22.8%)22 (24.4%)0.685
Quetiapine27 (16.2%)11 (12.2%)0.437
Aripiprazole14 (8.4)8 (9%)0.846
Perphenazine9 (5.4%)7 (7.8%)0.421